University of California San Francisco
<p>Robert Kaestner, PhD, a professor in the Department of Economics at the Institute of Government and Public Affairs at the University of Illinois, will deliver a health policy seminar at UCSF on February 2.</p>
Richard K. Olney, MD, founding director of the ALS Treatment and Research Center at UCSF and a pioneer in clinical research on amyotrophic lateral sclerosis (ALS), has died at age 64, following his own eight-year battle with the disease.
<p>Bioinformatics was the focus of this year’s daylong UCSF School of Medicine leadership retreat on January 20. Campus leaders examined the question of how to optimally develop, organize and integrate clinical-outcome data, research data, business intelligence, and population data so that information is accessible and usable to empower research and improve medical practice.</p>
<p>More than 300 people — many of them University of California faculty, students and staff — will gather at UC Berkeley on February 4, for the second UC Global Health Day, sponsored by the UC Global Health Institute.</p>
<p>UCSF Alumnus E. Leong Way, 95, was among members of the UCSF community to celebrate the Lunar New Year during an event at UCSF on Jan. 24.</p>
<p>The UCSF community is invited to the first Chancellor’s Concert Series of 2012 with a performance by violinist Leor Maltinski and cellist Angela Lee today (Jan. 26).</p>
<p>John Corrin Hutchinson, MD, or “Hutch” to many, professor emeritus and Distinguished Fellow of the American College of Cardiology, passed away peacefully on Jan. 14, 2012. He was 84.</p>
The Athena Breast Health Forum will host the first of an ongoing series of live discussions between breast cancer experts, health care providers, patients and community members about critical issues and advances in breast health on February 7.
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.